Core Viewpoint - Microelectrophysiology's stock price has shown a significant increase this year, with a 31.67% rise, indicating strong market interest and potential growth in the medical device sector [1][2]. Financial Performance - For the period from January to September 2025, Microelectrophysiology reported a revenue of 336 million yuan, reflecting a year-on-year growth of 15.65% [2]. - The net profit attributable to shareholders for the same period was 41.92 million yuan, showing a slight increase of 0.46% year-on-year [2]. Stock Market Activity - As of November 7, the stock price of Microelectrophysiology was 25.07 yuan per share, with a trading volume of 1.03 billion yuan and a turnover rate of 3.23%, leading to a total market capitalization of 11.798 billion yuan [1]. - The stock has experienced a 5.03% increase over the last five trading days and a 16.39% increase over the last 20 days [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders increased to 9,580, while the average number of tradable shares per person decreased by 8.26% to 13,033 shares [2][3]. - The largest shareholder is Huatai-PineBridge Innovation Medicine Mixed A, holding 4.7284 million shares, an increase of 308,600 shares from the previous period [3].
微电生理跌2.07%,成交额1.03亿元,主力资金净流入702.36万元